Terminal
Stocks
Spotlight
News

Stocks
Healthcare
NASDAQ
TVTX

Market Cap: $6.11B

TI

Travere Therapeutics, Inc.

TVTX

NASDAQ (NASDAQ Global Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

Cashu

Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Cashu Markets Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin94.41%

EBITDA Margin0.26%

EBIT Margin-9.74%

Pre-tax Margin-11.34%

Net Profit Margin-7.35%

Earnings Yield-0.71%

Valuation Multiples

Price / Book250.49

Price / Sales10.33

Price / Earnings-146.02

PEG1.28

Forward PEG0.01

EV / Sales11.18

EV / EBITDA4280.92

EV / Operating Cash Flow71.30

EV / Free Cash Flow128.30

Price / Free Cash Flow118.61

Price / Operating Cash Flow66.26

Cash Flow & Capital

Free Cash Flow / Share$0.55

Operating Cash Flow / Share$0.99

Free Cash Flow Yield0.84%

Capex / Revenue6.96%

Capex / Operating Cash Flow44.43%

Capex / Depreciation0.65

Stock Compensation / Revenue10.26%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio4.05

Quick Ratio3.99

Cash Ratio0.77

Debt / Assets0.77

Debt / Capital0.96

Debt / Equity25.16

Long-Term Debt / Capital0.96

Debt / Market Cap9.97%

Net Debt / EBITDA323.30

Solvency Ratio0.02

Financial Leverage32.60

Efficiency & Working Capital

Asset Turnover0.74

Fixed Asset Turnover49.28

Inventory Turnover4.22

Receivables Turnover7.33

Payables Turnover4.41

Days Sales Outstanding49.77

Days Inventory Outstanding86.46

Days Payables Outstanding82.7

Operating Cycle136.23

Cash Conversion Cycle53.52

Working Capital Turnover1.62

Returns & Quality

Return on Equity-55.79%

Return on Assets-5.44%

Return on Invested Capital-6.19%

ROCE-6.25%

Return on Tangible Assets-6.51%

Operating Return on Assets-5.97%

Income Quality-1.37

Tax Burden0.65

Interest Burden1.16

Balance Sheet & Intrinsic Metrics

Enterprise Value$6.61B

Invested Capital$606.63M

Working Capital$463.12M

Tangible Asset Value$-107M

Net Current Asset Value$-159.7M

Graham Net-Net-$2.37

Book Value / Share$0.26

Tangible Book Value / Share-$1.14

Cash / Share$5.23

Financial Health Scores

Piotroski Score5

Altman Z-Score3.22

Revenue$591.33M

EBIT$-57.59M

Market Cap$6.11B

Working Capital$463.12M

Retained Earnings$-1.54B

Total Assets$799.36M

Total Liabilities$774.84M